BioCentury | May 20, 2020
Management Tracks

Former Allergan execs join Merck spinout; plus Ping An ousts Tao, and updates from Mirati, Evox, Ardelyx, Akcea, Horama and more

...therapy company Horama S.A. appointed Benedikt Timmerman as chairman. Timmerman is a venture partner at IRDI...
BioCentury | May 13, 2019
Financial News

May 13 Financial Quick Takes: Biotech trio update IPO plans, plus Vedanta, TreeFrog

...in a series A round led by XAnge. New investor Galia Gestion and existing investors Irdi...
BioCentury | Oct 20, 2017
Financial News

Antabio raises EUR7.3M series A

...million ($8.6 million) on Oct. 16 in a series A round from iXO Private Equity, IRDI...
BioCentury | Oct 16, 2017
Financial News

Antabio raises €7.3M in series A

...it raised €7.3 million ($8.6 million) in a series A round from iXO Private Equity, IRDI...
BioCentury | Jun 22, 2015
Emerging Company Profile

Singling out ovarian cancer

...partners: LFB S.A. Number of employees: 7 Funds raised: €3.6 million ($4 million) Investors: Innobio, Irdi...
BioCentury | Oct 4, 2010
Company News

Pfenex, Rapid Micro Biosystems, VaxDesign Corp., Northrop Grumman Corp., Novartis, 3M, Infectious Disease Research Institute (IRDI), PATH, U.S. Department of He

...AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland 3M Co. (NYSE:MMM), St. Paul, Minn. Infectious Disease Research Institute (IRDI...
...which will receive about $5.2 million initially and up to $9.4 million with the options; IRDI...
Items per page:
1 - 6 of 6
BioCentury | May 20, 2020
Management Tracks

Former Allergan execs join Merck spinout; plus Ping An ousts Tao, and updates from Mirati, Evox, Ardelyx, Akcea, Horama and more

...therapy company Horama S.A. appointed Benedikt Timmerman as chairman. Timmerman is a venture partner at IRDI...
BioCentury | May 13, 2019
Financial News

May 13 Financial Quick Takes: Biotech trio update IPO plans, plus Vedanta, TreeFrog

...in a series A round led by XAnge. New investor Galia Gestion and existing investors Irdi...
BioCentury | Oct 20, 2017
Financial News

Antabio raises EUR7.3M series A

...million ($8.6 million) on Oct. 16 in a series A round from iXO Private Equity, IRDI...
BioCentury | Oct 16, 2017
Financial News

Antabio raises €7.3M in series A

...it raised €7.3 million ($8.6 million) in a series A round from iXO Private Equity, IRDI...
BioCentury | Jun 22, 2015
Emerging Company Profile

Singling out ovarian cancer

...partners: LFB S.A. Number of employees: 7 Funds raised: €3.6 million ($4 million) Investors: Innobio, Irdi...
BioCentury | Oct 4, 2010
Company News

Pfenex, Rapid Micro Biosystems, VaxDesign Corp., Northrop Grumman Corp., Novartis, 3M, Infectious Disease Research Institute (IRDI), PATH, U.S. Department of He

...AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland 3M Co. (NYSE:MMM), St. Paul, Minn. Infectious Disease Research Institute (IRDI...
...which will receive about $5.2 million initially and up to $9.4 million with the options; IRDI...
Items per page:
1 - 6 of 6